D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia (Q30450078)

13 August 2017

D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia (English)

1 reference

13 August 2017

0 references

0 references

1 reference

ChEBI release 2020-05-28

1

Donald C Goff

1 reference

PMC publication ID

3446239

13 August 2017

language of work or name

English

0 references

publication date

23 February 2012

1 reference

13 August 2017

Schizophrenia Bulletin

1 reference

13 August 2017

38

1 reference

13 August 2017

5

1 reference

13 August 2017

936-941

1 reference

d-cycloserine facilitation of cognitive behavioral therapy for delusions in schizophrenia

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Does abnormal sleep impair memory consolidation in schizophrenia?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Impairment in long-term retention of preference conditioning in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Extinction memory is impaired in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Once-weekly D-cycloserine effects on negative symptoms and cognition in schizophrenia: an exploratory study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Novel regional and developmental NMDA receptor expression patterns uncovered in NR2C subunit-beta-galactosidase knock-in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Effects of D-cycloserine on extinction: translation from preclinical to clinical work

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Effects of D-cycloserine on negative symptoms in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Consolidation of human motor cortical neuroplasticity by D-cycloserine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Double-blind, placebo-controlled, crossover trial of D-cycloserine adjuvant therapy for treatment-resistant schizophrenia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Multiple trace theory of human memory: computational, neuroimaging, and neuropsychological results

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Mechanisms of use-dependent plasticity in the human motor cortex

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

D-cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed in Xenopus oocytes

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study

20 June 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Functional magnetic resonance imaging studies of schizophrenic patients during word production: effects of D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Modulation of brain and serum glutamatergic concentrations following a switch from conventional neuroleptics to olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Placebo-controlled trial of D-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

A six-month, placebo-controlled trial of D-cycloserine co-administered with conventional antipsychotics in schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

D-cycloserine facilitates extinction the first time but not the second time: an examination of the role of NMDA across the course of repeated extinction sessions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Effects of multiple exposures to D-cycloserine on extinction of conditioned fear in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Glycine binding primes NMDA receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Dysfunctional neural plasticity in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/SCHBUL/SBS012

Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Reduced sleep spindle activity in schizophrenia patients

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

D-cycloserine added to clozapine for patients with schizophrenia

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3446239

Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients

26 November 2018

1 reference

12 December 2020

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

1 reference

12 December 2020

A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia

1 reference

12 December 2020

Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia

1 reference

12 December 2020

D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study

1 reference

12 December 2020

d-Cycloserine therapy of psychosis by symptom provocation

1 reference

12 December 2020

Identifiers

DOI

10.1093/SCHBUL/SBS012

1 reference

13 August 2017

1 reference

PMC publication ID

3446239

13 August 2017

PubMed publication ID

22368237

1 reference

PMC publication ID

3446239